Ezutromid

Generic Name: Ezutromid

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₉H_₁₅NO_₃S

CAS Number: 945531-77-1

Unique Ingredient Identifier: 645R07LF0D

Background: Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)

Phase 2

Terminated

Conditions: Duchenne Muscular Dystrophy

Interventions: Drug: Ezutromid

First Posted Date: 2016-08-08

Last Posted Date: 2020-01-02

Lead Sponsor: Summit Therapeutics

Target Recruit Count: 43

Registration Number: NCT02858362

Locations: 🇺🇸
Nemours Children's Clinic, Orlando, Florida, United States
🇬🇧
Bristol Children's Hospital, Bristol, United Kingdom
🇬🇧
Heart of England NHS Foundation Trust - Heartlands Hospital, Birmingham, United Kingdom

and more 13 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy